巴西生物制剂市场:在挑战和法规不断变化中强劲增长

The Brazilian biologicals market has seen significant growth due to its favorable regulatory environment, low barriers to entry, and government support for biological products, writes AgbioInvestor’s Lawrence Middler in a recent issue of AgriBusiness Global DIRECT.

Upcoming regulations, such as the Bioinputs Law, aim to streamline the market and encourage adoption, despite concerns over on-farm production. To fully understand the evolving dynamics to maximize growth in this promising market, read Middler’s full article (链接在这里).

隐藏图片